Correlation Between Celularity and EFFECTOR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Celularity and EFFECTOR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celularity and EFFECTOR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celularity and EFFECTOR Therapeutics, you can compare the effects of market volatilities on Celularity and EFFECTOR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celularity with a short position of EFFECTOR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celularity and EFFECTOR Therapeutics.
Diversification Opportunities for Celularity and EFFECTOR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Celularity and EFFECTOR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Celularity and EFFECTOR Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EFFECTOR Therapeutics and Celularity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celularity are associated (or correlated) with EFFECTOR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EFFECTOR Therapeutics has no effect on the direction of Celularity i.e., Celularity and EFFECTOR Therapeutics go up and down completely randomly.
Pair Corralation between Celularity and EFFECTOR Therapeutics
If you would invest 1.25 in Celularity on September 3, 2024 and sell it today you would earn a total of 0.75 from holding Celularity or generate 60.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 2.22% |
Values | Daily Returns |
Celularity vs. EFFECTOR Therapeutics
Performance |
Timeline |
Celularity |
EFFECTOR Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Celularity and EFFECTOR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Celularity and EFFECTOR Therapeutics
The main advantage of trading using opposite Celularity and EFFECTOR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celularity position performs unexpectedly, EFFECTOR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EFFECTOR Therapeutics will offset losses from the drop in EFFECTOR Therapeutics' long position.Celularity vs. Celularity | Celularity vs. Quantum Si incorporated | Celularity vs. Humacyte | Celularity vs. Surrozen Warrant |
EFFECTOR Therapeutics vs. Celularity | EFFECTOR Therapeutics vs. Humacyte | EFFECTOR Therapeutics vs. NRx Pharmaceuticals | EFFECTOR Therapeutics vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |